Originalartikel 2020

  • Kiemer AK. 2020. Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19? eBioMedicine, Commentary 61:103086
  • Dahlem C, Siow WX, Lopatniuk M, Fai Tse WK, Kessler SM, Kirsch SH, Hoppstädter J, Vollmar, AM, Müller R, Luzhetskyy ABartel K, Kiemer AK. 2020. Thioholgamide A, a new anti-proliferative anti-tumor agent, modulates macrophage polarization and metabolism. Cancers 12:1288
  • Valbuena Perez JV, Linnenberger R, Dembek A, Bruscoli S, Riccardi C, Schulz MH, Meyer MR, Kiemer AK, Hoppstädter J. 2020. Altered glucocorticoid metabolism represents a feature of macroph-aging. Aging Cell 19:e13156
  • Hoppstädter J, Valbuena Perez JV, Linnenberger R, Dahlem C, Legroux TM, Hecksteden A, Tse WKF, Flamini S, Andreas A, Herrmann J, Herr Ch, Müller R, Meyer T, Bals R, Riccardi C, Bruscoli S, Kiemer AK. 2020. The glucocorticoid-induced leucine zipper (GILZ) mediates statin-induced muscle damage. FASEB J 34:4684-470
  • Messner M, Schmitt S, Ardelt MA, Fröhlich T, Müller M, Pein H, Huber-Cantonati P, Ortler C, Koenig LM, Zobel L, Koeberle A, Arnold GJ, Rothenfusser S, Kiemer AK, Gerbes AL, Zischka, Vollmar AM, Pachmayr J. 2020. Metabolic implication of tigecycline as an efficacious second-line treatment for sorafenib-resistant hepatocellular carcinoma, FASEB J 34:11860–11882
  • Voitsekhovskaia I, Paulus C, Dahlem C, Rebets Y, Nadmid S, Zapp J, Axenov-Gribanov D, Rückert C, Timofeyev M, Kalinowski J, Kiemer AK, Luzhetskyy A. 2020. Baikalomycins A-C, new aquayamycin-type angucyclines isolated from lake Baikal derived Streptomyces sp. IB201691-2A. Microorganisms 8:680
  • Goes A, Lapuhs P, Kuhn T, Schulz E, Richter R, Panter F, Dahlem C, Koch M, Garcia R, Kiemer AK, Müller R, Fuhrmann G. 2020. Myxobacteria-derived outer membrane vesicles: potential applicability against intracellular infections. Cells 9:194